Trials / Unknown
UnknownNCT05038449
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
An IIT, Randomized, Single-Center, Open-Lable, Standard Therapy Controlled Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shanghai Public Health Clinical Center · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed for single-center, randomized, open label, standard therapy controlled. 60 COVID-19 subjects with a treatment period of 10 days and follow-up until 28 days after enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colchicine Tablets | Colchicine Tablets (Each tablet contains colchicine 0.5mg) |
| DRUG | Standard therapy | Standard therapy for COVID-19 according to the Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial 8th Edition) |
Timeline
- Start date
- 2021-09-06
- Primary completion
- 2023-06-01
- Completion
- 2023-09-01
- First posted
- 2021-09-09
- Last updated
- 2021-09-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05038449. Inclusion in this directory is not an endorsement.